Scrip's Five Must-Know Things - 5 November 2024

Audio roundup of selected biopharma industry content from Scrip over the business week ended 1 November 2024. In this episode: Lilly plans DTC tirzepatide ads; Pfizer’s Bourla defends strategy; expert views from BioFuture; China retains attractions for some; and AbbVie’s Aliada acquisition. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things